Search Results
                            266 Results for 'Therapeutics & Vaccines'                        
                        
                            PAGE 8 OF 11                        
                    Technology
Synthesis Of Small Molecule Histone Deacetylase 6 Degraders, Compounds Formed Thereby, And Pharmaceutical Compositions Containing Them
            Histone deacetylase (“HDAC”)-selective inhibitors covalently bonded to a linker covalently bonded to an E3 ubiquitin ligase ligand, and salts thereof; pharmaceutical compositions containing them; ...            
Learn More
        Learn More
            Weiping Tang, Ka Yang, Hao Wu | P180321US03
        
    Technology
Use Of A Rotifer-Derived Compound And Its Analogs For Preventing Schistosomiasis
            The present disclosure relates provides compounds according to Formula I or Formula II as well as compositions including such compounds useful for the prevention of schistosomiasis infection and/or sw...            
Learn More
        Learn More
            Phillip Newmark, Jonathan Sweedler, Ning Yang, Jiarong Gao, Peter Yau | P180311US02
        
    Technology
Gene Editing-Based Method Of Attenuating The Beta-Amyloid Pathway
            Described herein are CRISPR/Cas9 constructs designed for the C-terminal truncation of human amyloid precursor protein (APP) as well as methods of making and using such a construct.            
Learn More
        Learn More
            Subhojit Roy, Jichao Sun | P170275US02
        
    Technology
Antifungal Compounds
            Compounds of formula (I) or formula (II), compositions and methods useful for treating and/or preventing a fungal infections are provided. wherein the substituents are as defined in the appended claim...            
Learn More
        Learn More
            Cameron Currie, Ethan Van Amam, Clarissa Sit, Antonio Ruzzini, Jon Clardy, Adrian Pinto-Tomas | P170089US03
        
    Technology
Recombinant Influenza Viruses With Stabilized Ha For Replication In Eggs
            Modified influenza virus neuraminidases are described herein that improve viral replication, thus improving the yield of vaccine viruses.  Expression of such modified neuraminidases by influenza virus...            
Learn More
        Learn More
            Yoshihiro Kawaoka, Shinya Yamada, Shiho Chiba | P200038US02
        
    Technology
Circular Strained Zymogen Compositions And Methods Of Use
            Disclosed herein are circular zymogens of RNase 1 that have a proteolytic cleavage site and are activated by a specific protease. These circular zymogens are useful for treatment of disorders that are...            
Learn More
        Learn More
            Ronald Raines, Ian Windsor | P190190US02
        
    Technology
Modified Clostridial Neurotoxins As Vaccines And Conjugate Vaccine Platforms
            Provided herein are engineered non-catalytic, non-toxic tetanus toxin variants and methods of using such engineered tetanus toxin variants as low dose, protective vaccines that are non-toxic and more ...            
Learn More
        Learn More
            Eric Johnson, Sabine Pellett, William Tepp, Joseph Barbieri, Amanda Przedpelski | P190179US02
        
    Technology
Improved Influenza Virus Replication For Vaccine Development
            An isolated recombinant influenza virus is provided having PA, PB1, PB2, NP, NS, M, NA and HA viral segments, wherein the PB1 viral segment encodes a PB1 with a residue other than isoleucine at positi...            
Learn More
        Learn More
            Yoshihiro Kawaoka, Gabriele Neumann, Jihui Ping | P190171US02
        
    Technology
HLF-VC1 Master Cell Bank for Vaccine Development
            FDA-qualified cell lines must be used for virus production for human vaccines. There are relatively few of these lines available and several (WI-38, MRC-5) used for virus production are becoming senes...            
Learn More
        Learn More
            James Gern | P160170US01
        
    Technology
A Novel Series of Antimicrobials Target Bacteria Membranes to Overcome Antibiotic Resistance
            Drug resistant pathogens continue to emerge as the rate of the development of new antimicrobials to combat them continues to decline. Alarmingly, slow-growing bacteria associated with dangerous and pr...            
Learn More
        Learn More
            Douglas Weibel, Ye Jin Eun, Marie Foss, Katherine Hurley | P120204US02
        
    Technology
Oligolactic Acid-Paclitaxel and Oligolactic Acid-Docetaxel Prodrugs for Injection
            PTX, DTX, rapamycin and selumetinib are potent chemotherapeutic agents useful in the treatment of a variety of cancers. Due to their limited water solubility, PTX and DTX are commonly formulated for p...            
Learn More
        Learn More
            Glen Kwon, Yu Tong (Tony) Tam | P160169US03
        
    Technology
Compounds and Methods for Modulating Frataxin Expression in Friedreich’s Ataxia
            Friedreich’s Ataxia (FRDA) is a neurodegenerative disorder without treatments to halt or reverse disease progression, affecting roughly 9,000 Americans. FRDA is caused by triplet expansion in the fi...            
Learn More
        Learn More
            Aseem Ansari, Graham Erwin, Matthew Grieshop | P160232US07
        
    Technology
Gene Correction of Pompe Disease and Other Autosomal Recessive Disorders via CRISPR and other RNA-Guided Nucleases
            Pompe disease is a rare autosomal recessive genetic disease (mutations from both parent carriers have to be inherited by the offspring to see symptoms) that typically affects children during developme...            
Learn More
        Learn More
            Krishanu Saha, Jared Carlson-Stevermer, Lucille Kohlenberg | P190021US02
        
    Technology
Bacterial Membrane Nanoparticles as an Immunotherapy System for Cancer Treatment
            Cancer immunotherapy – a therapy that stimulates and employs the body’s own immune system – is one of the most promising new approaches for treating cancer. Despite its tremendous potential, it ...            
Learn More
        Learn More
            Shaoqin Gong, Zachary Morris, Mingzhou Ye, Ravi Patel, Paul Sondel | P180331US02
        
    Technology
Bioengineered Vocal Fold Mucosa for Voice Restoration
            Voice impairment (dysphonia) affects an estimated 20 million people in the U.S., resulting in reduced quality of life and direct health care costs exceeding $11 billion per year. Between 60 and 80 per...            
Learn More
        Learn More
            Nathan Welham, Changying Ling | P140307US02
        
    Technology
Inhibiting Quorum Sensing in Staphylococcus Epidermidis, a Health Care Pathogen
            Staphylococcus epidermidis is an important Gram-negative bacterial pathogen in hospital-acquired infections, and the most common cause of infections on indwelling medical devices. The costs related to...            
Learn More
        Learn More
            Helen Blackwell, Tian Yang | P150348US02
        
    Technology
Phospholipid Ether Analogs for Treating and Imaging Pediatric Solid Tumors
            Currently there is only one well-studied and established tumor-targeting radioactive agent in pediatric oncology (131I-MIBG), which only targets neuroblastoma and other rare neuroendocrine tumors. It ...            
Learn More
        Learn More
            Mario Otto, Bryan Bednarz, Jamey Weichert, Dana Baiu | P160325US02
        
    Technology
Engineered Probiotics as Systemic Therapeutic Delivery Platform
            Polypeptides, such as enzymes, antibodies, hormones and cytokines, are useful therapeutic agents. However, routes for systemically introducing such polypeptides to a subject are limited. Oral administ...            
Learn More
        Learn More
            Jan Peter Van Pijkeren, Alan Attie, Mark Keller, Jeehwan Oh | P160109US02
        
    Technology
Novel Small Molecule SIRT6 Activators/Inhibitors
            The epigenetic modifier SIRT6 is of the sirtuin class of proteins. In transgenic mice, increased SIRT6 expression lowers LDL and triglyceride levels, improves glucose tolerance and increases mitochond...            
Learn More
        Learn More
            John Denu, Weiping Tang | P160306US01
        
    Technology
Compounds to Treat Hyperlipidemia and Fatty Liver Disease
            Hyperlipidemia is a condition strongly associated with obesity and is an independent risk factor for the development of coronary heart disease. To help combat hyperlipidemia, the pharmaceutical indust...            
Learn More
        Learn More
            Mark Keller, Alan Attie, Sheldon Engelhorn, Nikolai Sepetov, Sergei Romanov, David Bernlohr | P110006US01
        
    Technology
Enzyme Aids Intranasal Drug Delivery
            Currently, delivering drugs directly into the brain requires invasive surgery. This is because a tight cellular layer called the blood-brain barrier (BBB) not only prevents harmful substances from ent...            
Learn More
        Learn More
            Robert Thorne, Jeffrey Lochhead | P120322US02
        
    Technology
New Compounds for Treating High Blood Cholesterol and More
            Indole is one of the most abundant heterocycles in pharmaceuticals and bioactive natural products, such as indometacin, a non-steroid anti-inflammatory drug, and vincristine, a natural product used to...            
Learn More
        Learn More
            Weiping Tang, Xiaoxun Li | P150140US02
        
    Technology
Methods and Compositions for Treating Prostate Cancer Using DNA Vaccines
            Prostate cancer is a significant health risk for men over the age of 50 and currently is a pervasive health threat with as many as 200,000 new cases diagnosed each year in the US alone. At present, t...            
Learn More
        Learn More
            Douglas McNeel, Brian Olson | P05235US
        
    Technology
Combinatorial Androgen Deprivation With An Androgen Receptor Vaccine
            The androgen receptor (AR) is a steroid hormone receptor that plays a crucial role in the development of normal prostate tissue, as well as in the progression of prostate cancer. Patients with metasta...            
Learn More
        Learn More
            Douglas McNeel, Brian Olson | P160108US02
        
    Technology
Use of Salate Derivatives to Treat Multiple Sclerosis
            Multiple sclerosis (MS) is a chronic inflammatory autoimmune disease affecting 2.5 million people worldwide. The disease is difficult to manage and there is no cure. The underlying mechanism of MS pro...            
Learn More
        Learn More
            Hector DeLuca, Lori Plum, Steven Marling, Yanping Wang | P160384US02